House Clears “Must-Pass” Measure to Reauthorize FDA User Fees
- June 10, 2022
By a 392-28 margin, the House approved June 6 legislation (H.R. 7667) to reauthorize Food and Drug Administration (FDA) user fees, which are set to expire September 30.
ARTICLE TAGS
You must be logged in to access this content.